AstraZeneca PLC
1458.50
27-November-24 10:49:45
15 minutes delayed
Stocks
+4.50
+0.31%
Today's range
1449.00 - 1464.00
ISIN
N/A
Source
NASD.OMX SE
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 11:38:29 By NASDAQ Stocks
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 11:34:42 By NASDAQ US Markets
-
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
02 Jan 2024 09:45:15 By NASDAQ US Markets
-
AstraZeneca To Buy Gracell For Up To $1.2 Bln
26 Dec 2023 03:23:07 By NASDAQ US Markets
-
AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis
21 Dec 2023 20:47:36 By NASDAQ US Markets
-
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
21 Dec 2023 20:44:53 By MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 Dec 2023 04:30:35 By Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 Dec 2023 03:42:28 By NASDAQ US Markets
-
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
10 Dec 2023 23:22:28 By NASDAQ US Markets
-
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
10 Dec 2023 09:09:34 By NASDAQ US Markets
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 Dec 2023 07:46:15 By NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 Dec 2023 09:27:21 By NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 Dec 2023 08:12:31 By NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 Dec 2023 02:39:09 By NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 Nov 2023 09:21:15 By NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 Nov 2023 09:20:24 By NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 Nov 2023 03:04:07 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 Nov 2023 11:57:01 By NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 Nov 2023 03:55:47 By NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 Nov 2023 09:14:44 By NASDAQ Stocks